Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer

Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer

Abstract Background Cancer-associated fibroblasts (CAFs) have been shown to support tumor development in a variety of cancers. Different markers were applied to classify CAFs in order to elucidate their impact on tumor progression. However, the exact mechanism by which CAFs enhance cancer developmen...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Anna Muchlińska, Anna Nagel, Marta Popęda, Jolanta Szade, Magdalena Niemira, Jacek Zieliński, Jarosław Skokowski, Natalia Bednarz-Knoll, Anna J. Żaczek
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	BMC 2022-06-01
Σειρά:	Cellular & Molecular Biology Letters
Θέματα:	Cancer-associated fibroblast Luminal breast cancer Alpha-smooth muscle actin Osteopontin
Διαθέσιμο Online:	https://doi.org/10.1186/s11658-022-00351-7

Παρόμοια τεκμήρια

Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility
ανά: Yoshinobu Kariya, κ.ά.
Έκδοση: (2021-09-01)

Osteopontin and breast cancer metastasis: Possible role of genistein on the regulation of osteopontin
ανά: Kitboklang Khongsti, κ.ά.
Έκδοση: (2021-11-01)

Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
ανά: Daniella Mattos, κ.ά.
Έκδοση: (2024-09-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
ανά: Magdalena Niedolistek, κ.ά.
Έκδοση: (2020-04-01)

Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
ανά: Marta Popeda, κ.ά.
Έκδοση: (2021-03-01)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
ανά: Josip Maleš, κ.ά.
Έκδοση: (2021-02-01)

Potential of osteopontin in the management of epithelial ovarian cancer
ανά: Cerne Katarina, κ.ά.
Έκδοση: (2019-01-01)

Osteopontin in Cancer: Mechanisms and Therapeutic Targets
ανά: Yoshinobu Kariya, κ.ά.
Έκδοση: (2022-08-01)

Osteopontin and Cancer: Insights into Its Role in Drug Resistance
ανά: Chengcheng Hao, κ.ά.
Έκδοση: (2023-01-01)

Meta-analysis of Osteopontin splice variants in cancer
ανά: Yu An, κ.ά.
Έκδοση: (2023-04-01)

Role of osteopontin in cancer development and treatment
ανά: Zhihua Yan, κ.ά.
Έκδοση: (2023-10-01)

Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms
ανά: Bruna Prunes Pena Baroni Viana, κ.ά.
Έκδοση: (2021-10-01)

Osteopontin as a tumor marker in ovarian cancer
ανά: Shikha Rani, κ.ά.
Έκδοση: (2022-01-01)

Investigating the Role of Osteopontin (OPN) in the Progression of Breast, Prostate, Renal and Skin Cancers
ανά: Gautam Kundu, κ.ά.
Έκδοση: (2025-01-01)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
ανά: Kalhara R. Menikdiwela, κ.ά.
Έκδοση: (2022-11-01)

Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study
ανά: T U Kars, κ.ά.
Έκδοση: (2023-01-01)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
ανά: Atif Ali Hashmi, κ.ά.
Έκδοση: (2018-01-01)

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer
ανά: Serafin Morales Murillo, κ.ά.
Έκδοση: (2021-03-01)

LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER
ανά: M. V. Zavjalova, κ.ά.
Έκδοση: (2016-02-01)

Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer
ανά: Zhao Fujun, κ.ά.
Έκδοση: (2012-10-01)

Clinical-radiomics nomogram based on the fat-suppressed T2 sequence for differentiating luminal and non-luminal breast cancer
ανά: Yaxin Guo, κ.ά.
Έκδοση: (2024-10-01)

Role of actin-binding proteins in prostate cancer
ανά: Fangzhi Fu, κ.ά.
Έκδοση: (2024-07-01)

Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age
ανά: Runnak A Majid, κ.ά.
Έκδοση: (2017-04-01)

Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
ανά: Piotr Ziółkowski, κ.ά.
Έκδοση: (2022-09-01)

Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
ανά: Zhuce Shao, κ.ά.
Έκδοση: (2023-01-01)

Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
ανά: Mohammad Kamalabadi-Farahani, κ.ά.
Έκδοση: (2022-09-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
ανά: Dorsay Sadeghian, κ.ά.
Έκδοση: (2022-02-01)

Osteopontin in Cardiovascular Diseases
ανά: Kohsuke Shirakawa, κ.ά.
Έκδοση: (2021-07-01)

MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
ανά: M. V. Zavyalova, κ.ά.
Έκδοση: (2016-02-01)

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
ανά: Kamil Mieczkowski, κ.ά.
Έκδοση: (2022-08-01)

Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer
ανά: Chengcheng Hao, κ.ά.
Έκδοση: (2021-07-01)

Differentially expressed miRNAs in Luminal and Basal-like breast cancer
ανά: Ming-Juan ZHAO, κ.ά.
Έκδοση: (2021-06-01)

Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case–control and systems biology study
ανά: Sepideh Mehrpour Layeghi, κ.ά.
Έκδοση: (2020-10-01)

Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma
ανά: Krisztina Jámbor, κ.ά.
Έκδοση: (2022-08-01)

Histopathological Patterns and Luminal Subtypes among Breast Cancer Patients in the Middle Euphrates Region of Iraq
ανά: Ahmed Mjali, κ.ά.
Έκδοση: (2022-08-01)

Osteopontin as a Biomarker in Chronic Kidney Disease
ανά: Satyesh K. Sinha, κ.ά.
Έκδοση: (2023-05-01)

Characterisation of Osteopontin in an In Vitro Model of Embryo Implantation
ανά: Stéphane C Berneau, κ.ά.
Έκδοση: (2019-05-01)

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity
ανά: Stefan Prekovic, κ.ά.
Έκδοση: (2023-10-01)

Prognostic role of immune environment in luminal B early breast cancer
ανά: Arlene Chan, κ.ά.
Έκδοση: (2023-04-01)

Platelet Concentration and Platelet/Lymphocyte Ratio as Prognostic Indicators in Luminal Breast Cancer
ανά: Angela Della’Santa Rubio O. Rönnau, κ.ά.
Έκδοση: (2023-01-01)